Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$45,380,036
-$9,504,991 QoQ
Shares Held
1,884,553
-3.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#186
of 2,821 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $567,998,433 across 14 Drug Manufacturers - General names. PFE ranks #4 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
118,181 | $141,749,848 | |
| 2 | JNJ |
Johnson & Johnson
|
456,860 | $116,028,734 | |
| 3 | ABBV |
AbbVie Inc.
|
426,678 | $107,369,251 | |
| 4 | PFE |
Pfizer Inc
This page
|
1,884,553 | $45,380,036 | |
| 5 | MRK |
Merck & Co., Inc.
|
323,733 | $41,599,690 | |
| 6 | NVS |
Novartis AG
|
185,906 | $29,135,188 | |
| 7 | AMGN |
Amgen Inc
|
79,199 | $28,679,541 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
229,499 | $13,223,732 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,380,036 | 1,884,553 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $54,885,027 | 1,954,595 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $42,461,621 | 1,705,286 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $40,175,411 | 1,576,743 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,166,667 | 1,409,516 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $28,915,828 | 1,141,114 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $30,834,678 | 1,162,257 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $38,047,012 | 1,314,686 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $38,036,235 | 1,359,408 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,396,353 | 987,256 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,114,248 | 698,654 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $24,430,832 | 736,534 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $26,207,786 | 714,498 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $22,902,182 | 561,328 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $37,221,812 | 726,421 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $32,295,842 | 738,022 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $34,161,972 | 651,573 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,777,338 | 555,869 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $37,620,341 | 637,093 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $33,603,756 | 781,301 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $24,645,933 | 629,365 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $22,821,095 | 629,895 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $31,237,297 | 848,609 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $18,261,021 | 497,576 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||